Goelzer Investment Management, Inc. Eli Lilly & CO Transaction History

Goelzer Investment Management, Inc.

$1.71 Billion
Q4 2024

A detailed history of Goelzer Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Goelzer Investment Management, Inc. holds 547,438 shares of LLY stock, worth $406 Million. This represents 24.75% of its overall portfolio holdings.

Number of Shares

547,438

Previous 546,870 0.1%

Holding current value

$406 Million

Previous $484 Million 12.77%

% of portfolio

24.75%

Previous 26.7%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$727.2 - $932.06 $413,049 - $529,410	568 Added 0.1%	547,438 $423 Million
Q3 2024 Oct 04, 2024	SELL	$772.14 - $960.02 $16.6 Million - $20.6 Million	-21,459 Reduced 3.78%	546,870 $484 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $10.9 Million - $13.7 Million	-15,072 Reduced 2.58%	568,329 $515 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $3.49 Million - $4.66 Million	-5,886 Reduced 1.0%	583,401 $454 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $31.1 Million - $36.6 Million	-59,135 Reduced 9.12%	589,287 $344 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $244 Million - $336 Million	561,464 Added 645.67%	648,422 $348 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $46,648 - $62,374	-133 Reduced 0.15%	86,958 $40.8 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $91,325 - $107,257	294 Added 0.34%	87,091 $29.9 Million
Q4 2022 Jan 20, 2023	BUY	$321.55 - $374.67 $85,210 - $99,287	265 Added 0.31%	86,797 $0
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $66,411 - $75,682	224 Added 0.26%	86,532 $28 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $214,064 - $251,343	-768 Reduced 0.88%	86,308 $28 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $94,580 - $117,538	-403 Reduced 0.46%	87,076 $24.9 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $422,268 - $524,037	1,878 Added 2.19%	87,479 $24.2 Million
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $3.55 Million - $4.37 Million	-16,017 Reduced 15.76%	85,601 $19.8 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $595,273 - $769,981	-3,297 Reduced 3.14%	101,618 $23.3 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $976,225 - $1.26 Million	-5,941 Reduced 5.36%	104,915 $19.6 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $26.3 Million - $34.8 Million	-201,334 Reduced 64.49%	110,856 $18.7 Million
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $20,617 - $23,847	-141 Reduced 0.05%	312,190 $46.2 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $223,865 - $269,419	1,641 Added 0.53%	312,331 $51.3 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $10,595 - $13,114	89 Added 0.03%	310,690 $43.1 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $96,228 - $119,187	-900 Reduced 0.29%	310,601 $40.8 Million
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $64,074 - $69,696	-600 Reduced 0.19%	311,501 $34.8 Million
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $5,539 - $6,466	-50 Reduced 0.02%	312,101 $34.6 Million
Q1 2019 May 03, 2019	BUY	$111.31 - $131.02 $32.3 Million - $38.1 Million	290,557 Added 1345.55%	312,151 $40.5 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $114,054 - $127,775	-1,077 Reduced 4.75%	21,594 $2.5 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $242,726 - $303,365	-2,827 Reduced 11.09%	22,671 $2.43 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $250,718 - $287,746	-3,312 Reduced 11.5%	25,498 $2.18 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $114,802 - $135,517	-1,547 Reduced 5.1%	28,810 $2.23 Million
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $629,790 - $675,522	7,686 Added 33.9%	30,357 $2.56 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $1.75 Million - $1.94 Million	22,671	22,671 $1.94 Million

Others Institutions Holding LLY

# of Institutions

4,031

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $705B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Goelzer Investment Management, Inc. with notifications on news.

Account

Goelzer Investment Management, Inc. Eli Lilly & CO Transaction History